Key result
Restrictive intravenous fluid regimen during and after minilaparotomy abdominal aortic aneurysm repair significantly reduced the length of ICU stay (1.2 vs. 1.97 days) and hospital stay (4.33 vs. 6.20 days) compared to standard fluid administration.
Why the study?
Does an intra- and postoperative intravenous restrictive fluid regimen reduce postoperative morbidity, mortality, and length of stay in patients undergoing elective minilaparotomy abdominal aortic aneurysm repair?
RCT (n=60)
Sealed envelope method with computer-generated random numbers
Yes
Does an intra- and postoperative intravenous restrictive fluid regimen reduce postoperative morbidity, mortality, and length of stay in patients undergoing elective minilaparotomy abdominal aortic aneurysm repair?
Absolute Event Rate: 1.2% vs 1.97%
p-value: p=0.003
A restrictive intra- and postoperative intravenous fluid regimen significantly reduces nonlethal complications and shortens ICU and hospital stays in patients undergoing elective minilaparotomy AAA repair.
Supports restrictive fluids to shorten ICU/hospital stays after minilaparotomy AAA repair; extends goal-directed strategy evidence in vascular surgery.
Objective Elective minilaparotomy abdominal aortic aneurysm (AAA) repair is associated with a significant number of complications involving respiratory, cardiovascular, gastrointestinal, and central nervous systems, with mortality ranging up to 5%. In our study, we tested the hypothesis that intra- and postoperative intravenous restrictive fluid regimen reduces postoperative morbidity and mortality, and improves the outcome of minilaparotomy AAA repair. Methods From March 2009 to July 2013, 60 patients operated due to AAA were included in a prospective randomized controlled trial (RCT). About the administration of fluid during the operation and in the early postoperative period, all the patients were randomized into two groups: the group of standard fluid administration (S-group, 30 patients) and the group of reduced fluid administration (R-group, 30 patients). The verification of the treatment success was measured by the length of intensive care unit (ICU) stay, duration of hospitalization after the procedure, as well as the number and type of postoperative complications and mortality. This prospective RCT was registered in a publicly accessible database ClinicalTrials.gov with unique Identifier ID: NTC01939652. Results Total fluid administration and administration of blood products were significantly lower in R-group as compared with S-group (2,445.5 mL vs. 3308.7 mL, p = 0.004). Though the number of nonlethal complications was significantly lower in R-group (2 vs. 9 patients, p = 0.042), the difference in lethal complications remained nonsignificant (0 vs. 1 patient, p = ns). The average ICU stay (1.2 vs. 1.97 days, p = 0.003) and duration of postoperative hospital stay (4.33 vs. 6.20 days, p = 0.035 for R-group and S-group, respectively) were found to be significantly shorter in R-group. Conclusion Intra- and postoperative restrictive intravenous fluid regimen in patients undergoing minilaparotomy AAA repair significantly reduces postoperative morbidity, and shortens ICU and overall hospital stay. Even though incidence of lethal complication was lower in R-group, the difference did not reach statistical significance. Therefore, we may assume that this study was probably underpowered to estimate the differences in mortality between R- and S-groups. Further multicentric, sufficiently powered RCTs are needed to confirm these findings and to clarify effect of restrictive fluid management on mortality.
No takes yet. Share an insight, caveat, or question.
Petričević et al. (2015) conducted an RCT in Infrarenal abdominal aortic aneurysm (n=60). Restrictive fluid regimen vs. Standard fluid regimen (Intraoperative 15 mL/kg/h, postoperative 150-200 mL/h) was evaluated on Length of ICU stay (days) (p=0.003). Restrictive intravenous fluid regimen during and after minilaparotomy abdominal aortic aneurysm repair significantly reduced the length of ICU stay (1.2 vs. 1.97 days) and hospital stay (4.33 vs. 6.20 days) compared to standard fluid administration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: